Citable company snapshot
Labcorp's latest SEC-sourced 2026-03-31 period shows $3.54B in revenue and $277.80M in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| xbrl:Revenues | Mar 31, 2026 | $3.54B | $3.52B | +0.6% |
| xbrl:GrossProfit | Mar 31, 2026 | $1.01B | $993.20M | +2.1% |
| xbrl:OperatingIncomeLoss | Mar 31, 2026 | $380.80M | $267.60M | +42.3% |
| xbrl:NetIncomeLoss | Mar 31, 2026 | $277.80M | $164.70M | +68.7% |
| xbrl:NetCashProvidedByUsedInOperatingActivities | Mar 31, 2026 | $191.50M | $614.20M | -68.8% |
| Free Cash Flow (computed) | Mar 31, 2026 | $70.50M | $490.30M | -85.6% |
Source: SEC EDGAR XBRL; period Mar 31, 2026; filed May 4, 2026; accession 0000920148-26-000139.
Continue research
Follow same-sector companies and source explainers connected to the overview view.
A factual guide to market capitalization, shares outstanding, public float, and why share-count definitions matter.
A factual guide to dividends, share repurchases, and how companies can return capital to shareholders.
A factual guide to book value, tangible book value, and balance-sheet net worth measures.
A factual guide to the core 10-K sections investors use for company context: business description, risk factors, MD&A, financial statements, and segment disclosures.